🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Gait Parameters in Breast Cancer Receiving Chemotherapy Patients

Recruitingn/aAges 40 Years - 50 YearsFemaleAdly A Adam
NCT07894133 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Breast cancer is considered the most common type of malignancies, it is the most frequently diagnosed representing around 2.3 million cases. Where, their chemotherapy may cause fatigue affecting the overall quality of patient's life. Gait and balance are fundamental for activities of daily living and maintaining functional independence.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Age ranged from 40 to 50 years old. * Female patients. * Suffering from breast cancer, and receiving chemotherapy. * Will be assessed before chemotherapy, 3 months and 6 months after chemotherapy. * All enrolled patients will have signed their informed consent signed. Exclusion Criteria: * No history of prior chemotherapy. * Current metastases. * Orthopedic problems that affect balance and gait. * Diabetic patients with neuritis. * Peripheral neuropathy. * Polyarthritis.
💊

What it tests

  • Gait parameter assessment
📍

Where

1 site
National Cancer Institute
Cairo, Egypt
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy